Home › Synovial Sarcoma
Synovial Sarcoma clinical trials recruiting in the U.S.
13 studies for Synovial Sarcoma are recruiting participants at sites across the United States.
Cities with the most studies
- Boston, MA5 studies
- Chicago, IL4 studies
- Houston, TX4 studies
- St. Louis, MO3 studies
- New York City, NY3 studies
By state
- California5 studies
- Illinois4 studies
- Massachusetts5 studies
- Missouri3 studies
- New York3 studies
- Pennsylvania3 studies
- Texas4 studies
Recently updated studies
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT05711615First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06644755N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
RecruitingEarly phase 1
Ages 18 to 80 · All sexes · Updated Aug 27, 2026 · NCT07261657SPEARHEAD-3 Pediatric Study
RecruitingPhase 1/2
Ages 2 to 21 · All sexes · Updated Aug 11, 2026 · NCT05642455NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
RecruitingPhase 1
Ages 16 to 80 · All sexes · Updated Jul 29, 2026 · NCT06083883AOH1996 for the Treatment of Refractory Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT05227326Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
RecruitingPhase 1/2
6 Months – 25 Years · All sexes · Updated Jun 30, 2026 · NCT06625190XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT06571734Synovial Sarcoma Registry / Biospecimen Repository
RecruitingObservational study
All ages · All sexes · Updated Jun 9, 2026 · NCT05910307Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Feb 25, 2026 · NCT03016819HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
RecruitingPhase 1
Ages 1 to 25 · All sexes · Updated Jan 22, 2026 · NCT04995003ACTengine® IMA203 Combined With mRNA-4203
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jan 8, 2026 · NCT06946225From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.